Patent details

EP3679046 Title: PHOSPHAPLATIN COMPOUNDS AS IMMUNO-MODULATORY AGENTS AND THERAPEUTIC USES THEREOF

Basic Information

Publication number:
EP3679046
PCT Application Number:
US2018049980
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP188528574
PCT Publication Number:
WO2019051246
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHOSPHAPLATIN COMPOUNDS AS IMMUNO-MODULATORY AGENTS AND THERAPEUTIC USES THEREOF
French Title of Invention:
COMPOSÉS DE PHOSPHAPLATINE UTILISÉS EN TANT QU'AGENTS IMMUNOMODULATEURS ET LEURS UTILISATIONS THÉRAPEUTIQUES
German Title of Invention:
PHOSPHAPLATIN-VERBINDUNGEN ALS IMMUNMODULATORISCHE MITTEL UND IHRE THERAPEUTISCHE VERWENDUNG
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
08/12/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
24/01/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
08/11/2023
Unitary Effect Registration Date:
24/01/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
07/09/2018
Grant date:
08/11/2023
EP Publication Date:
15/07/2020
PCT Publication Date:
14/03/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/11/2023
EP B1 Publication Date:
08/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
07/09/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/11/2023
 
 

Name:
Promontory Therapeutics Inc.
Address:
1350 Ave. of the Americas, 23rd Fl., New York, NY 10019, United States (US)

Inventor

1

Name:
PRICE, Matthew
Address:
United States (US)

2

Name:
AMES, Tyler
Address:
United States (US)

Priority

Priority Number:
201762555676 P
Priority Date:
08/09/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/675; C07F 15/00; A61K 33/24; A61P 35/00; A61K 39/39; A61K 39/00; A61K 45/06;

Publication

European Patent Bulletin

1

Issue number:
202345
Publication date:
08/11/2023
Description:
Grant (B1)

2

Issue number:
202403
Publication date:
17/01/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202409
Publication date:
28/02/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages